Cost analysis approach: Economic burden associated with diabetes mellitus patients in kenya
- Autores: Jesse Kang’ethe Mukuria
- Localización: International Journal of Professional Business Review: Int. J. Prof.Bus. Rev., ISSN 2525-3654, ISSN-e 2525-3654, Vol. 10, Nº. 9, 2025 (Ejemplar dedicado a: Continuous publication; e05664)
- Idioma: inglés
- Enlaces
-
Resumen
Objectives: The study aimed at estimating the economic burden of Diabetes mellitus in Kenya from a societal perspective. One of the non-communicable diseases that directly and indirectly drains a person's income is diabetes mellitus because of the high expense of treating the condition and its complications.
Theoretical Framework: The study applied the Modern Theory of Cost to evaluate both direct and indirect costs of Diabetes Mellitus.
Method: The cost of illness approach methodology was applied to determine the study's findings and outcomes. All of the expenses associated with diabetes mellitus, both direct and indirect, are identified and quantified using this method.
Results and Discussion: The results showed that the adult cases reported in 2024 resulted in a total economic cost of KSH 48,027,901,376.79, equivalent to KSH 86,975.14 per diabetes mellitus patient. The total direct costs accounted for the highest proportion of the overall costs at 61% (KSH 29,419,292,062.83), whereas indirect costs accounted for 39% of the total economic costs (KSH 18,608,609,313.97). Costs of medicines accounted for the highest costs over the total economic costs at about 29%, followed by the income lost while seeking care at 19.7%. Other costs that accounted for more than 10% of the total costs include productivity losses (19%), diagnostic tests (13%), and travel (12%). Less than 5% came from the remaining cost categories.
Implications and value of the study are: first to improve care, attempts should be made to lower the price of these medications. 19% of the observed high indirect expenses are primarily related to the income that people lose while seeking medical attention. Secondly the financial burden of diabetes mellitus can be lessened and the population's health and contributions to society can be improved by having access to reasonably priced medicines and other health services like diabetes education and routine blood glucose screening programs.
Originality: The study value is to contribute to managerial improvement in the management of costs related to diabetes mellitus through expanding coverage of programs like Social Health Authority to all citizens with different economic status.
